Interventions Are Urgently Implemented to Control the Epidemic in COVID-19 with Non-Severe and Non-Critical Outside of China
,
Abstract
No Abstract
1. Hui DS, E IA, Madani TA et al (2020). The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis, 91:264-266.
2. Huang C, Wang Y, Li X et al (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506.
3. Pan L, Mu M, Ren HG et al (2020). Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, [Epub ahead of print].
4. Guan W, Ni Z, Hu Y, Liang W, et al (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, DOI: 10.1056/NEJMoa2002032.
5. Wang D, Hu B, Hu C et al (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, doi: 10.1001/jama.2020.1585.
6. Xu X, Wu X, Jiang X et al (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ, 368:m606
7. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi, 41(2):145-51.
8. Zhou F, Yu T, Du R et al (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, https://doi.org/10.1016/S0140-6736(20)30566-3
9. Wang C, Liu L, Hao X et al (2020). Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. medRxiv, https://doi.org/10.1101/2020.03.03.20030593.
2. Huang C, Wang Y, Li X et al (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506.
3. Pan L, Mu M, Ren HG et al (2020). Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol, [Epub ahead of print].
4. Guan W, Ni Z, Hu Y, Liang W, et al (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med, DOI: 10.1056/NEJMoa2002032.
5. Wang D, Hu B, Hu C et al (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA, doi: 10.1001/jama.2020.1585.
6. Xu X, Wu X, Jiang X et al (2020). Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ, 368:m606
7. The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020). The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi, 41(2):145-51.
8. Zhou F, Yu T, Du R et al (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, https://doi.org/10.1016/S0140-6736(20)30566-3
9. Wang C, Liu L, Hao X et al (2020). Evolving Epidemiology and Impact of Non-pharmaceutical Interventions on the Outbreak of Coronavirus Disease 2019 in Wuhan, China. medRxiv, https://doi.org/10.1101/2020.03.03.20030593.
| Files | ||
| Issue | Vol 49 No Supple 1 (2020) | |
| Section | Letter to the Editor | |
| DOI | https://doi.org/10.18502/ijph.v49iS1.3689 | |
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
ZHENG Y, LAI F, TIAN M, NI Z, YU H, WANG F. Interventions Are Urgently Implemented to Control the Epidemic in COVID-19 with Non-Severe and Non-Critical Outside of China. Iran J Public Health. 2020;49(Supple 1):138-140.
